Cellyan Biotechnology HKPD
NASDAQ HKPD
$0.12 +0.01 (+6.78%)
At close: Sep 21, 2026 · 4:00 PM EDT

Cellyan Biotechnology (HKPD) Liabilities and Shareholders Equity (2024 - 2026)

Cellyan Biotechnology's (HKPD) quarterly Liabilities and Shareholders Equity came in at $12.8 million in Q1 2026, up 36.39% year-over-year from $9.4 million in Q1 2025, and up 33.32% quarter-over-quarter from $9.6 million in Q3 2025.

Analysis

Cellyan Biotechnology (HKPD) Liabilities and Shareholders Equity (2024 - 2026) Analysis & Trends

Cellyan Biotechnology (HKPD) has reported Liabilities and Shareholders Equity for 3 consecutive years, with $12.8 million the latest figure, recorded in Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 36.39% year-over-year to $12.8 million in Q1 2026; TTM through Mar 2026 was $42.1 million, a N/A change from a year earlier, with the FY2026 full-year figure at $12.8 million, up 36.39% from the prior year.
  • Liabilities and Shareholders Equity was $12.8 million for Q1 2026 at Cellyan Biotechnology, up from $9.6 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $12.8 million in Q1 2026 and troughed at $8.7 million in Q1 2024.
  • A 3-year average of $10.1 million and a median of $9.6 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
  • Across the five-year window, Liabilities and Shareholders Equity declined 5.2% in 2025 and surged 36.39% in 2026, its largest moves.
  • Over 3 years, Liabilities and Shareholders Equity stood at $10.2 million in 2024, then dropped by 5.2% to $9.6 million in 2025, then surged by 33.32% to $12.8 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $12.8 million (Q1 2026), $9.6 million (Q3 2025), and $9.4 million (Q1 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Copart 27.11 Bn 23.77 Bn 732.88 Mn 9.65 Bn
2 Expeditors International Of Washington 24.83 Bn 23.80 Bn 1.09 Bn 5.13 Bn
3 C. H. Robinson Worldwide 17.92 Bn 17.76 Bn 1.11 Bn 5.84 Bn
4 Rb Global 15.40 Bn 14.87 Bn 935.50 Mn 12.49 Bn
5 Ryder System 9.14 Bn 9.14 Bn 1.45 Bn 16.09 Bn
6 Landstar System 5.78 Bn 5.43 Bn 308.86 Mn 1.74 Bn
7 GXO Logistics 5.27 Bn 4.53 Bn 508.00 Mn 12.37 Bn
8 Rxo 3.34 Bn 3.32 Bn 302.00 Mn 3.46 Bn
9 Hub 1.98 Bn 1.89 Bn 250.84 Mn 2.90 Bn
10 Cellyan Biotechnology 2.58 Mn 2.36 Mn - 12.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 12.84 Mn
Sep 30, 2025 9.63 Mn
Mar 31, 2025 9.42 Mn
Sep 30, 2024 10.16 Mn
Mar 31, 2024 8.67 Mn
API Access

Cellyan Biotechnology Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=HKPD&period=max&api_key=YOUR_API_KEY